Ironwood Pharmaceuticals | IRWD - Cost Of Sales

Stock Price
4.57
Daily Change
0.12 2.70%
Monthly
12.01%
Yearly
168.82%
Q1 Forecast
4.74

Ironwood Pharmaceuticals reported $29.83M in Cost of Sales for its fiscal quarter ending in September of 2024.





Cost Of Sales Change Date
Acadia Pharmaceuticals USD 21.65M 913K Sep/2025
Agios Pharmaceuticals USD 1.68M 22K Sep/2025
Almirall EUR 193.79M 12.62M Jun/2025
Alnylam Pharmaceuticals USD 200.15M 57.2M Sep/2025
Amarin USD 16.89M 18.51M Mar/2025
Ardelyx USD 3.98M 10.84M Sep/2025
Astellas Pharma JPY 149.13B 10.88B Dec/2025
AstraZeneca USD 2.8B 328M Sep/2025
Charles River Laboratories USD 693.46M 20.52M Sep/2025
Exact Sciences USD 266.81M 18.18M Sep/2025
Halozyme Therapeutics USD 73M 8.88M Sep/2025
Incyte USD 99M 20.23M Sep/2025
Ironwood Pharmaceuticals USD 29.83M 560K Sep/2024
MacroGenics USD 44.3M 5.4M Sep/2025
Moderna USD 207M 88M Sep/2025
Myriad Genetics USD 61.9M 600K Sep/2025
Pacira USD 48.6M 6.59M Sep/2025
PTC Therapeutics USD 23.32M 7.83M Sep/2025
Sarepta Therapeutics USD 151.45M 1.77M Sep/2025
Takeda JPY 401.15B 184.07B Dec/2025
Ultragenyx Pharmaceutical USD 27.99M 4.99M Sep/2025